|

Outcome of HSCT in Children at Ramathibodi Hospital

RECRUITINGSponsored by Mahidol University
Actively Recruiting
SponsorMahidol University
Started2020-05-08
Est. completion2030-05-07
Eligibility
Healthy vol.Accepted

Summary

Firstly, to study the treatment outcomes of hematopoietic stem cell transplantation (HSCT) in patients with hematologic diseases, cancers, and other conditions treated at the Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital. Secondly, to evaluate factors that may influence treatment outcomes in patients with hematologic diseases, cancers, and other conditions undergoing hematopoietic stem cell transplantation. Lastly, to study complications occurring after hematopoietic stem cell transplantation in patients with hematologic diseases, cancers, and other conditions, in order to identify opportunities to further improve treatment outcomes.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients with hematologic, malignant, or other diseases who underwent HSCT

Exclusion Criteria:

* Incomplete or loss of medical records

Conditions4

CancerGenetic DiseasesHematologic Disease and DisordersMalignancies

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.